Reirradiation
Sponsors
Dan Zandberg, Sun Yat-sen University, European Organisation for Research and Treatment of Cancer - EORTC, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Baptist Health South Florida
Conditions
Abdominal CancerBreast Cancer RecurrentCarcinoma, Squamous Cell of Head and NeckFirst Progression of GlioblastomaHead and Neck NeoplasmNasopharyngeal CarcinomaNasopharyngeal DiseasesNasopharyngeal Neoplasms
Phase 1
Phase 2
Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck
CompletedNCT02289209
Start: 2016-03-09End: 2024-08-31Updated: 2025-03-06
IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.
NCT03854838
Start: 2019-05-01End: 2023-02-01Updated: 2022-04-29
Phase 3
Unknown Phase
Radiotherapy & Total Neoadjuvant Therapy for Recurrent Rectal Cancer in Previously Irradiated Patients, an Italian Association for Radiotherapy and Clinical Oncology (AIRO)-GI Platform: a Multi-centre Prospective Observational Study
RecruitingNCT05984576
Start: 2023-06-21End: 2031-06-05Target: 88Updated: 2023-08-09
Ablative Stereotactic MR-Guided Adaptive Reirradiation
Active, not recruitingNCT06397573
Start: 2024-06-05End: 2027-06-01Target: 10Updated: 2026-02-17
Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK)
Not yet recruitingNCT07528339
Start: 2026-04-01End: 2037-03-31Target: 500Updated: 2026-04-14
Reirradiation and Total Ablative Strategies for Recurrent Gynecologic Cancer
RecruitingNCT07667192
Start: 2026-06-11End: 2036-12-01Target: 500Updated: 2026-06-24